Quick Answer
Oncology Institute, Inc. reported Net Income of -$60.61 million for fiscal year 2025.
Oncology Institute, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$60.61M | +6.3% |
| 2024 | -$64.66M | +22.2% |
| 2023 | -$83.07M | -54750.0% |
| 2022 | $152.0K | +101.4% |
| 2021 | -$10.93M | +23.7% |
| 2020 | -$14.32M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$16.50M | -2.4% | +3.0% |
| June 30, 2025 | -$17.01M | -9.9% | +13.2% |
| March 31, 2025 | -$19.59M | +1.5% | -21.5% |
| September 30, 2024 | -$16.11M | +7.5% | -4.1% |
| June 30, 2024 | -$15.48M | +8.4% | +22.2% |
| March 31, 2024 | -$19.89M | +33.7% | -14.2% |
| September 30, 2023 | -$17.42M | -551.4% | -3.1% |
| June 30, 2023 | -$16.90M | -209.9% | +43.7% |
- Oncology Institute, Inc. showed an increase of +6.3% in Net Income compared to the prior fiscal year.
- Over the 2020–2025 period, Oncology Institute, Inc.’s net income has declined by 323.2% (from -$14.32 million to -$60.61 million).
- The most recent figure is from Oncology Institute, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: